The Effect Of Doxorubicin Loaded Silica Nanoparticles On The Expression Of PARP-1 In Head And Neck Squamous Carcinoma Cell Line: In Vitro Study.
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 6, Pages 2035-2047
AbstractNanotechnology is a new branch of science, which is going to be a major driving force behind the impending technological revolution in the 21st century. Although Doxorubicin (DOX) is one of the preferred chemotherapeutic drugs for the treatment of oral squamous cell carcinoma (OSCC), several studies pointed out that it was limited due to multidrug resistance (MDR) like the over-expression of DNA damage repair agents as poly (ADP-ribose) polymerase-1 (PARP-1). Accordingly, it seemed very interesting to explore the effect of DOX loaded mesoporous silica nanoparticles (MSNs) with their outstanding properties in comparison to the conventional DOX on HNO-97 cell line, in an attempt to introduce a novel efficient therapeutic modality for OSCC.
- Article View: 131
- PDF Download: 236